Anemia, characterized by a decrease in the number of red blood cells or less than the normal quantity of hemoglobin in the blood, is a common hematologic disorder. The condition can be intricate due to its multiple etiologies, diverse clinical presentations, and the complexity of diagnostic tests. A systematic approach to diagnosis is imperative for appropriate patient management.
An initial complete blood count (CBC) and reticulocyte count serve as the foundation for anemia evaluation. The mean corpuscular volume (MCV) on the CBC can classify anemia as microcytic, normocytic, or macrocytic, providing clues to the underlying etiology. The reticulocyte count helps determine whether the anemia is due to decreased production, increased destruction, or blood loss.
Further investigations depend on the initial classification. Microcytic anemia often warrants iron studies, while macrocytic anemia may necessitate vitamin B12 and folate levels. Normocytic anemia, especially with low reticulocyte count, could require bone marrow examination. Hemolysis indicators, such as lactate dehydrogenase, haptoglobin, and bilirubin, may be required if hemolytic anemia is suspected.
In complex cases, specialized tests like hemoglobin electrophoresis, osmotic fragility test, or tests for paroxysmal nocturnal hemoglobinuria may be needed. Genetic testing could be considered in cases of suspected hereditary anemia.
Understanding the complexity of anemia requires a comprehensive, stepwise approach to its diagnosis. Starting from a thorough history and physical examination to a systematic interpretation of laboratory tests, each step is crucial in unraveling the etiology of anemia. This approach not only aids in precise diagnosis but also guides the appropriate therapeutic strategy, ensuring optimal patient care.
1.
FDA Expands Use of T-DXd in Early HER2+ Breast Cancer
2.
younger kidney cancer survivors are more susceptible to heart problems.
3.
Gene therapy for glioblastoma is effectively created by researchers.
4.
Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?
5.
Patellar Resurfacing in Total Knee Replacement; Patient Messaging Trends
1.
Hematopoietic Aging and Long-Term Disease Risk: Mechanisms, Clinical Impact, and Emerging Therapeutic Strategies
2.
Clinical Guidance for Survivorship-Focused Cancer Care
3.
Transformative Insights in Oncology in Daily Practice
4.
Revolutionizing Cancer Treatment with Trilaciclib: How a New Drug is Transforming Outcomes
5.
How AI, Multi-Omics, and Real-World Evidence are Redefining Oncology Research and Shaping Cancer Care?
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
2.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
3.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation